JAZZ News and Press, Jazz Pharmaceuticals plc From 06/09/20

DUBLIN , June 9, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals") today announced the pricing of $850 million aggregate principal amount of 2.000% exchangeable senior notes due 2026 in a private offering (the "offering") by Jazz Investments I Limited...

Jazz Pharmaceuticals' (NASDAQ: JAZZ ) wholly-owned subsidiary intends to offer $850M aggregate principal amount of exchangeable senior notes due 2026 in a private offering. More news on: Jazz Pharmaceuticals plc, Healthcare stocks news, , Read more ...

DUBLIN , June 8, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to offer, subject to market conditions and other factors, $850 million aggregate principal amount of ex...

Investment Thesis As pandemic fears dry up the new patient enrollments, Jazz Pharmaceuticals plc ( JAZZ ) has revised down the 2020 sales guidance, reflecting the impact of rising unemployment on payor reimbursements. The company's excessive reliance on Xyrem is at risk as rival companies ...

Insider buying almost doubled last week with insiders purchasing $209.6 million of stock compared to $107.94 million in the week prior. Selling also increased with insiders selling $1.47 billion of stock last week compared to $1.33 billion in the week prior. Sell/Buy Ratio: The insider Sel...

Over the past week, the S&P 500 rose again by 2.75%, almost recovering from its YTD losses. With economies restarting, novel optimism about vaccines and better-than-feared job losses last week, the stock market is behaving very optimistically. Of course, the biggest reason for this strong ...

With fears that the second wave of the COVID-19 pandemic is on the horizon, many investors are on the lookout for defensive stocks whose businesses will see little to no impact from a second wave of infections. In cases like this, the best defense is a good offense, and it's usually companies wi...

DUBLIN , May 27, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following virtual investor conferences: Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 4:30 p.m....

DUBLIN , May 14, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its partners will present seven new abstracts at the virtual American Society of Clinical Oncology (ASCO) Annual Meeting from May 29-June 2, 2020 and six abstracts at the virtu...

DUBLIN , May 11, 2020 /PRNewswire/ --   Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Kim Sablich as executive vice president, general manager of North America , effective June 1, 2020. In this role, Ms. Sablich will lead Jazz's newly...